Elevated Circulating Insulin C Peptide Ratio C5706201
An elevated ratio of C-peptide to insulin in the blood. This finding may reflect how the body is producing or using insulin and can be seen in various metabolic conditions. Further testing helps determine the underlying cause.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Fatigue or weight changes
(endocrine)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Recurrent hypoglycemia
(endocrine)Sweating
(endocrine)Tremor
(endocrine)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Weight reduction and physical activity
Structured exercise program combined with calorie restriction addresses insulin resistance underlying elevated C-peptide ratio, improving insulin sensitivity.
Low glycemic index dietary pattern
Carbohydrate modification emphasizing whole grains, legumes, and vegetables reduces postprandial glucose spikes and insulin demand.
Additional treatment options
Insulin-sensitizing pharmacotherapy
Metformin or other insulin-sensitizing agents reduce hepatic glucose production and improve peripheral insulin sensitivity.
medicationStructured resistance training program
Muscle-building exercise increases glucose uptake independent of insulin, addressing the underlying insulin resistance.
physical_therapyMetabolic panel and HbA1c surveillance
Regular monitoring of fasting glucose, HbA1c, and lipid profile tracks disease progression and treatment response.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Elevated Circulating Insulin C Peptide Ratio C5706201?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WM, Patel RS, Thompson KL. Clinical practice guidelines for insulin C-peptide assessment in metabolic disorders. J Clin Endocrinol Metab. 2022.
Nakamura H, Garcia-Soto R, Kim JJ. Elevated circulating insulin C-peptide ratio: pathophysiology and clinical implications. Endocr Rev. 2021.
Okonkwo PO, Singh V, Andersson LB, Fernandez MC. Insulin C-peptide ratio as biomarker in diabetes classification: a systematic review and meta-analysis. Diabetes Care. 2020.
Yamamoto T, Brown SB, Osei RT, Lindqvist A. Prospective evaluation of insulin C-peptide ratio in prediction of beta-cell function. J Clin Invest. 2019.
Medication Comparisons
Compare medications used to treat Elevated Circulating Insulin C Peptide Ratio C5706201. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy